Genomic polymorphism and allogeneic hematopoietic transplantation outcome

Biology of Blood and Marrow Transplantation

Volumn 12, Issue SUPPL. 1, 2006, Pages 19-27

  Mullighan, Charles G ^a   Petersdorf, Effie W ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Allogeneic hematopoietic transplantation; Cytokine; Graft versus host disease; HLA; KIR; Natural killer cell; Polymorphism

Indexed keywords

HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; NATURAL KILLER CELL RECEPTOR;

ALLELE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ARTICLE; CANCER RELAPSE; CANCER SURVIVAL; CELLULAR IMMUNITY; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HLA MATCHING; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; NATURAL KILLER T CELL; PHENOTYPE; RISK ASSESSMENT; RISK FACTOR;

ANIMALS; GENOME, HUMAN; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HUMANS; KILLER CELLS, NATURAL; MONOMERIC GTP-BINDING PROTEINS; POLYMORPHISM, GENETIC; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 29844454054     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2005.09.014     Document Type: Article

References (29)

1. E.W. Petersdorf M. Malkki Human leukocyte antigen matching in unrelated donor hematopoietic cell transplantation Semin Hematol. 42 2005 76-84
2. N. Flomenberg L.A. Baxter-Lowe D. Confer et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome Blood 104 2004 1923-1930
3. E.W. Petersdorf C. Anasetti P.J. Martin et al. Limits of HLA mismatching in unrelated hematopoietic cell transplantation Blood 104 2004 2976-2980
4. S.S. Farag T.A. Fehniger L. Ruggeri A. Velardi M.A. Caligiuri Natural killer cell receptors: New biology and insights into the graft-versus-leukemia effect Blood 100 2002 1935-1947
5. P. Parham K.L. McQueen Alloreactive killer cells: Hindrance and help for haematopoietic transplants Nat Rev Immunol. 3 2003 108-122
6. P. Parham Immunogenetics of killer cell immunoglobulin-like receptors Mol Immunol. 42 2005 459-462
7. L. Ruggeri M. Capanni E. Urbani et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants Science 295 2002 2097-2100
8. A. Velardi L. Ruggeri M. Capanni et al. Impact of NK cell alloreactivity on mismatched hematopoietic transplantation: An update on donor selection criteria and on transplantation outcomes [abstract] Blood 102 2003 527
9. S. Giebel F. Locatelli T. Lamparelli et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors Blood 102 2003 814-819
10. M. Bornhauser R. Schwerdtfeger H. Martin K.H. Frank C. Theuser G. Ehninger Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors Blood 103 2004 2860-2861
11. D. De Santis A. Bishara C.S. Witt et al. Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants Tissue Antigens 65 2005 519-528
12. M. Schaffer A. Aldener-Cannava M. Remberger O. Ringden O. Olerup Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation Tissue Antigens 62 2003 243-250
13. D.W. Beelen H.D. Ottinger S. Ferencik et al. Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias Blood 105 2005 2594-2600
14. F. Aversa A. Terenzi A. Tabilio et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse J Clin Oncol. 23 2005 3447-3454
15. Cooley S, McCullar V, Wangen R, et al. KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. Blood. In press.
16. K.C. Hsu C.A. Keever-Taylor A. Wilton et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes Blood 105 2005 4878-4884
17. S. Giebel F. Locatelli J. Wojnar et al. Increased risk of relapse for patients undergoing HLA-C matched URD-HSCT and lacking ligands for KIR2DL2/3 Bone Marrow Transplant. 35 2005 S152-S153
18. P. Loiseau C. Chen M.-L. Appert et al. The presence and number of activatory KIR (R+D-) impact the infection and survival status of patients transplanted with an HLA matched sibling donor [abstract 3339] Blood (ASH Annual Meeting Abstracts) 104 2004 912a
19. W. Leung R. Iyengar B. Triplett et al. Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors J Immunol. 174 2005 6540-6545
20. M.A. Cook D.W. Milligan C.D. Fegan et al. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia Blood 103 2004 1521-1526
21. S. Verheyden R. Schots W. Duquet C. Demanet A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation Leukemia 19 2005 1446-1451
22. J.Y. Sun L. Gaidulis A. Dagis et al. Killer Ig-like receptor (KIR) compatibility plays a role in the prevalence of acute GVHD in unrelated hematopoietic cell transplants for AML Bone Marrow Transplant 56 2005 525-530
23. C. Imai S. Iwamoto D. Campana Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells Blood 106 2005 376-383
24. J.L.M. Ferrara K.R. Cooke T. Teshima The pathophysiology of graft-vs.-host disease in: J.L. Ferrara K.R. Cooke H.J. Deeg eds Graft-vs.-Host Disease 2005 Marcel Dekker New York 1-34
25. C.G. Mullighan P.G. Bardy Advances in the genomics of allogeneic haemopoietic stem cell transplantation Drug Dev Res. 62 2004 273-292
26. A.M. Dickinson P.G. Middleton V. Rocha E. Gluckman E. Holler Genetic polymorphisms predicting the outcome of bone marrow transplants Br J Haematol. 127 2004 479-490
27. C.G. Mullighan S. Heatley K. Doherty et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation Blood 99 2002 3524-3529
28. V. Rocha R.F. Franco R. Porcher et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation Blood 100 2002 3908-3918
29. M. Mohty B. Gaugler C. Faucher The "cytokine storm" at the era of reduced intensity conditioning allogeneic stem cell transplantation Bone Marrow Transplant 35 2005 S79-S80